班佩多酸:对于他类药物不耐受患者及其他患者来说是一个新的参与者
Salvatore Giordano1, Carmen Anna Maria Spaccarotella2, Giovanni Esposito2
1Department of Medical and Surgical Sciences, Division of Cardiology, 'Magna Graecia' University, Catanzaro.
Current opinion in endocrinology, diabetes, and obesity
|December 14, 2023
概括
佩多酸 (BA) 有效降低了动脉质标记物,改善了对他类药物不耐受患者的治疗结果. 这种降胆固醇剂为预防心血管疾病提供了一个安全的替代方案.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 低密度脂蛋白 (LDL) 是动脉样硬化心血管疾病的主要原因.
- 类他类药物是管理较高的LDL胆固醇 (LDL-C) 的标准药物,但会引起肌肉骨方面的副作用,限制患者的坚持和有效性.
- 佩多酸 (BA) 通过抑制ATP-酸酶,一种在他类药物向前的酶,提供了一种新的治疗方法.
研究的目的:
- 审查bempedoic酸 (BA) 的疗效,安全性和临床影响.
- 概述BA在治疗失脂性血症中的当前使用指示.
- 突出正在进行的研究,研究BA的更广泛的应用.
主要方法:
- 审查目前关于贝佩多酸 (BA) 的证据.
- 来自临床试验的安全性和疗效数据的分析.
- 对患者临床结果和LDL-C降低的影响评估.
主要成果:
- 贝佩多酸 (BA) 显示,有机体标志物显著减少.
- BA改善了临床结果,特别是在对他类药物不耐受的患者中.
- BA可以独立于对他类药物的耐受性来实现LDL-C目标.
结论:
- 贝佩多酸 (BA) 是降低LDL-C和预防心血管事件的安全有效选择.
- BA为患有他类药物相关副作用的患者提供了有价值的替代方案.
- 进一步的研究将揭示BA在各种临床场景中的全部潜力.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
667
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
667
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
526
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
526
Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
487
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
487
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195


